Cite this: Functional Interleukin-17 Receptor A is Expressed in Central Nervous System Glia and Upregulated in Experimental Autoimmune Encephalomyelitis - Medscape - Apr 01, 2009. 1 Department of ...
3d
Medpage Today on MSNSome Psoriasis Biologics Better Than Others for Preventing Progression to PsAPsoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDIâ„¢for all indicationsmatching the reference product ...
Data reinforce dose-dependent mechanism with IMNN-001 100mg/m2 dose associated with 20% increase in IL-12 levels compared to 79mg/m2 doseResults ...
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...
The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...
2d
News Medical on MSNVitamin E significantly improves liver health in MASH patients, new study findsA 96-week clinical trial found that 300 mg of Vitamin E significantly improved liver histology and reduced inflammation in ...
Mepolizumab reduces asthma exacerbations among real-world patients with severe asthma and an eosinophilic phenotype.
A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...
Repurposing Drug Shows Promise in Fighting Aggressive Brain Tumors Oct. 17, 2024 — Research provides ... NK Cells Expressing Interleukin-21 Show Promising Antitumor Activity in Glioblastoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results